HAE vs MMED: stock comparison and AI forecast
Haemonetics Corp (HAE) and Minimed Group, Inc. (MMED) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
HAE Haemonetics Corp
- Market Cap
- $5.80B
- P/E Ratio
- 61.6x
- Size
- mid-cap
- AI Forecast
MMED Minimed Group, Inc.
- Market Cap
- $5.30B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- HAE and MMED have similar market capitalizations ($5.80B and $5.30B).
- HAE carries 1.83 times debt per unit of equity, against 0.30 times for MMED.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | HAE | MMED |
|---|---|---|
| Market Cap | $5.80B | $5.30B |
| P/E Ratio | 61.55x | – |
| P/B Ratio | 6.93x | 1.47x |
| EPS | $2.07 | – |
| Book Value/Share | $18.40 | $12.87 |
| Revenue/Share | $29.72 | – |
| FCF/Share | $6.40 | – |
Profitability & Margins
| Metric | HAE | MMED |
|---|---|---|
| ROIC | 7.6% | – |
| Gross Margin | 59.0% | – |
| Operating Margin | 11.7% | – |
| EBT Margin | 9.5% | – |
| Tax Rate | 26.2% | – |
Financial Health
| Metric | HAE | MMED |
|---|---|---|
| Current Ratio | 3.08x | 1.81x |
| Quick Ratio | 1.91x | 1.36x |
| D/E Ratio | 1.83x | 0.30x |
| Financial Leverage | 2.83x | 1.30x |
| Working Capital | $548M | $635M |
Cash Flow
| Metric | HAE | MMED |
|---|---|---|
| Operating Cash Flow | $328M | – |
| Free Cash Flow | $291M | – |
| Capital Spending | -$37M | – |
| OCF Growth YoY | 44.9% | – |
| FCF Growth YoY | 13.7% | – |
| FCF/Sales | 21.5% | – |
| CapEx/Sales | 2.7% | – |
Operational Efficiency
| Metric | HAE | MMED |
|---|---|---|
| Asset Turnover | 0.57x | – |
| Receivables Turnover | 6.3x | – |
| Inventory Turnover | 1.8x | – |
| Fixed Assets Turnover | 4.5x | – |
| Days Sales Outstanding | 58 days | – |
| Days Inventory | 202 days | – |
| Payables Period | 37 days | – |
| Cash Conversion Cycle | 223 days | – |
Income Statement
| Metric | HAE | MMED |
|---|---|---|
| Total Revenue | $1.35B | – |
| Operating Income | $160M | – |
| R&D Expense | $60M | – |
| SG&A Expense | $451M | – |
| Cost of Goods Sold | $554M | – |
Dividend & Shareholder Information
| Metric | HAE | MMED |
|---|---|---|
| Shares Outstanding | 46M | 281M |
| EPS Growth | -36.7% | – |
HAE vs MMED: stock comparison and AI forecast
Which is bigger, HAE or MMED?
HAE and MMED have similar market capitalizations ($5.80B and $5.30B).
Which one does Intratio's AI model rank higher, HAE or MMED?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.